Ketamine amplifies induced gamma frequency oscillations in the human cerebral cortex

European Neuropsychopharmacology

Volumn 25, Issue 8, 2015, Pages 1136-1146

  Shaw, Alexander D ^a,b   Saxena, Neeraj ^b,c   Jackson, Laura E ^b   Hall, Judith E ^b   Singh, Krish D ^a   Muthukumaraswamy, Suresh D ^d  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c Hamad Medical Coorporation Doha Qatar   (United Kingdom)

^d THE UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Gamma oscillations; Ketamine; Magnetoencephalography; Motor cortex; NMDA receptor; Visual cortex

Indexed keywords

KETAMINE; PLACEBO; ANTIDEPRESSANT AGENT;

AMPLITUDE MODULATION; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG INFUSION; GAMMA RADIATION; HIGH FREQUENCY OSCILLATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MAGNETOENCEPHALOGRAPHY; MALE; MOTOR CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SINGLE BLIND PROCEDURE; VISUAL CORTEX; ADULT; BETA RHYTHM; DRUG EFFECTS; GAMMA RHYTHM; MOTOR ACTIVITY; PHYSIOLOGY; VISION; YOUNG ADULT;

ADULT; ANTIDEPRESSIVE AGENTS; BETA RHYTHM; CROSS-OVER STUDIES; GAMMA RHYTHM; HUMANS; KETAMINE; MAGNETOENCEPHALOGRAPHY; MALE; MOTOR ACTIVITY; MOTOR CORTEX; SINGLE-BLIND METHOD; VISUAL CORTEX; VISUAL PERCEPTION; YOUNG ADULT;

EID: 84938742721     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.04.012     Document Type: Article

References (50)

1. Anver H., Ward P.D., Magony A., Vreugdenhil M. NMDA receptor hypofunction phase couples independent & gamma; oscillations in the rat visual cortex. Neuropsychopharmacology 2010, 36:519-528. 10.1038/npp.2010.183.
2. Autry A.E., Autry A.E., Adachi M., Adachi M., Nosyreva E., Nosyreva E., Na E.S., Na E.S., Los M.F., Los M.F., Cheng P.-F., Cheng P.-F., Kavalali E.T., Kavalali E.T., Monteggia L.M., Monteggia L.M. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 475:91-95. 10.1038/nature10130.
3. Bastos A.M., Briggs F., Alitto H.J., Mangun G.R., Usrey W.M. Simultaneous recordings from the primary visual cortex and lateral geniculate nucleus reveal rhythmic interactions and a cortical source for gamma-band oscillations. J. Neurosci. 2014, 34:7639-7644. 10.1523/JNEUROSCI.4216-13.2014.
4. Bekkers J.M., Stevens C.F. NMDA and non-NMDA receptors are co-localized at individual excitatory synapses in cultured rat hippocampus. Nature 1989, 341:230-233. 10.1038/341230a0.
5. Brunel N. What determines the frequency of fast network oscillations with irregular neural discharges? I. Synaptic dynamics and excitation-inhibition balance. J. Neurophysiol. 2003, 90:415-430. 10.1152/jn.01095.2002.
6. Buzsáki G., Wang X.-J. Mechanisms of gamma oscillations. Annu. Rev. Neurosci. 2012, 35:203-225. 10.1146/annurev-neuro-062111-150444.
7. Campbell A.E., Sumner P., Singh K.D., Muthukumaraswamy S.D. Acute Effects of Alcohol on Stimulus-Induced Gamma Oscillations in Human Primary Visual and Motor Cortices. Neuropsychopharmacology 2014, 1-10. 10.1038/npp.2014.58.
8. Carlén M., Meletis K., Siegle J.H., Cardin J.A., Futai K., Vierling-Claassen D., Rühlmann C., Jones S.R., Deisseroth K., Sheng M. A Critical Role for NMDA Receptors in Parvalbumin Interneurons for Gamma Induction and Behavior. Molecular Psychiatry 2011, 10.1038/mp.2011.31.
9. Cheyne D., Cheyne D., Bells S., Bells S., Ferrari P., Ferrari P., Gaetz W., Gaetz W., Bostan A.C., Bostan A.C. Self-paced movements induce high-frequency gamma oscillations in primary motor cortex. NeuroImage 2008, 42:332-342. 10.1016/j.neuroimage.2008.04.178.
10. Collingridge G.L., Isaac J.T.R., Wang Y.T. Receptor trafficking and synaptic plasticity. Nat. Publ. Group 2004, 5:952-962. 10.1038/nrn1556.
11. Cornwell, B.R., Cornwell, B.R., Salvadore, G., Salvadore, G., Furey, M., Furey, M., Marquardt, C.A., Marquardt, C.A., Brutsche, N.E., Brutsche, N.E., Grillon, C., Grillon, C., Zarate, C.A., Zarate, C.A., 2012. Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression. Biol. Psychiatry. 10.1016/j.biopsych.2012.03.029.
12. Duman R.S. Pathophysiology of depression: the concept of synaptic plasticity. Eur. Psychiatry 2002, 17(Suppl. 3):S306-S310.
13. Duman R.S., Duman R.S., Li N., Li N., Liu R.-J., Liu R.-J., Duric V., Duric V., Aghajanian G., Aghajanian G. Signaling pathways underlying the rapid antidepressant actions of ketamine. Biol. Psychiatry 2012, 62:35-41. 10.1016/j.neuropharm.2011.08.044.
14. Frohlich J., Van Horn J.D. Reviewing the ketamine model for schizophrenia. J. Psychopharmacol. 2014, 28:287-302. 10.1177/0269881113512909.
15. Gieselmann M.A., Thiele A. Comparison of spatial integration and surround suppression characteristics in spiking activity and the local field potential in macaque V1. Eur. J. Neurosci. 2008, 28:447-459. 10.1111/j.1460-9568.2008.06358.x.
16. Hakami T., Jones N.C., Tolmacheva E.A., Gaudias J., Chaumont J., Salzberg M., O'Brien T.J., Pinault D. NMDA receptor hypofunction leads to generalized and persistent aberrant γ oscillations independent of hyperlocomotion and the state of consciousness. PLoS One 2009, 4:e6755. 10.1371/journal.pone.0006755.
17. Harris J.E., Letson R.D., Buckley J.J. The use of CI-581, a new parenteral anesthetic, in ophthalmic practice. Trans. Am. Ophthalmol. Soc. 1968, 66:206-213.
18. Herrero J.L., Gieselmann M.A., Sanayei M., Thiele A. Attention-induced variance and noise correlation reduction in macaque V1 is mediated by NMDA receptors. Neuron 2013, 78:729-739. 10.1016/j.neuron.2013.03.029.
19. Hevers W., Hevers W., Hadley S.H., Hadley S.H., Luddens H., Luddens H., Amin J., Amin J. Ketamine, but not phencyclidine, selectively modulates cerebellar GABAA receptors containing 6 and subunits. J. Neurosci. 2008, 28:5383-5393. 10.1523/JNEUROSCI.5443-07.2008.
20. Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci. 2007, 27:11496-11500. 10.1523/JNEUROSCI.2213-07.2007.
21. Kollmar R., Kollmar R., Markovic K., Markovic K., Thürauf N., Thürauf N., Schmitt H., Schmitt H., Kornhuber J., Kornhuber J. Ketamine followed by memantine for the treatment of major depression. Aust. N. Z. J. Psychiatry 2008, 42:170. 10.1080/00048670701787628.
22. Krystal J.H., Sanacora G., Duman R.S. Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol. Psychiatry 2013, 73:1133-1141. 10.1016/j.biopsych.2013.03.026.
23. Li N., Lee B., Liu R.-J., Banasr M., Dwyer J.M., Iwata M., Li X.-Y., Aghajanian G., Duman R.S. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964. 10.1126/science.1190287.
24. Luscher B., Luscher B., Shen Q., Shen Q., Sahir N., Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol. Psychiatry 2010, 16:383-406. 10.1038/mp.2010.120.
25. Maeda F., Keenan J.P., Pascual-Leone A. Interhemispheric asymmetry of motor cortical excitability in major depression as measured by transcranial magnetic stimulation. Br. J. Psychiatry 2000, 177:169-173. 10.1192/bjp.177.2.169.
26. Muthukumaraswamy S.D. Functional Properties of Human Primary Motor Cortex Gamma Oscillations. J. Neurophysiol. 2010, 104:2873-2885. 10.1152/jn.00607.2010.
27. Muthukumaraswamy S.D. High-frequency brain activity and muscle artifacts in MEG/EEG: a review and recommendations. Front. Hum. Neurosci. 2013, 7:138. 10.3389/fnhum.2013.00138.
28. Muthukumaraswamy S.D. The use of magnetoencephalography in the study of psychopharmacology (pharmaco-MEG). J. Psychopharmacol. 2014, 10.1177/0269881114536790.
29. Muthukumaraswamy S.D., Carhart-Harris R.L., Moran R.J., Brookes M.J., Williams T.M., Errtizoe D., Sessa B., Papadopoulos A., Bolstridge M., Singh K.D., Feilding A., Friston K.J., Nutt D.J. Broadband cortical desynchronization underlies the human psychedelic state. J. Neurosci. 2013, 33:15171-15183. 10.1523/JNEUROSCI.2063-13.2013.
30. Muthukumaraswamy S.D., Myers J.F.M., Wilson S.J., NUTT D.J., Lingford-Hughes A., Singh K.D., Hamandi K. The effects of elevated endogenous GABA levels on movement-related network oscillations. NeuroImage 2012, 66C:36-41. 10.1016/j.neuroimage.2012.10.054.
31. Muthukumaraswamy S.D., Singh K.D. Functional decoupling of BOLD and gamma-band amplitudes in human primary visual cortex. Hum. Brain Mapp. 2009, 30:2000-2007. 10.1002/hbm.20644.
32. Muthukumaraswamy, S.D., Singh, K.D., 2012. Visual gamma oscillations: the effects of stimulus type, visual field coverage and stimulus motion on MEG and EEG recordings. NeuroImage 10.1016/j.neuroimage.2012.12.038.
33. Nagele, P., Duma, A., Kopec, M., Gebara, M.A., Parsoei, A., Walker, M., Janski, A., Panagopoulos, V.N., Cristancho, P., Miller, J.P., Zorumski, C.F., Conway, C.R., 2014. Nitrous oxide for treatment-resistant major depression: a proof-of-concept trial. Biol. Psychiatry. 10.1016/j.biopsych.2014.11.016.
34. Oke O.O., Oke O.O., Magony A., Magony A., Anver H., Anver H., Ward P.D., Ward P.D., Jiruska P., Jiruska P., Jefferys J.G.R., Jefferys J.G.R., Vreugdenhil M., Vreugdenhil M. High-frequency gamma oscillations coexist with low-frequency gamma oscillations in the rat visual cortex in vitro. Eur. J. Neurosci. 2010, 31:1435-1445. 10.1111/j.1460-9568.2010.07171.x.
35. Pascual-Leone A., Manoach D.S., Birnbaum R., Goff D.C. Motor cortical excitability in schizophrenia. Biol. Psychiatry 2002, 52:24-31. 10.1016/S0006-3223(02)01317-3.
36. Perry G., Brindley L.M., Muthukumaraswamy S.D., Singh K.D., Hamandi K. Evidence for increased visual gamma responses in photosensitive epilepsy. Epilepsy Res. 2014, 108:1076-1086. 10.1016/j.eplepsyres.2014.04.012.
37. Perry G., Perry G., Hamandi K., Hamandi K., Brindley L.M., Brindley L.M., Muthukumaraswamy S.D., Muthukumaraswamy S.D., Singh K.D., Singh K.D. The properties of induced gamma oscillations in human visual cortex show individual variability in their dependence on stimulus size. NeuroImage 2012, 68C:83-92. 10.1016/j.neuroimage.2012.11.043.
38. Ray S., Maunsell J.H.R. Differences in gamma frequencies across visual cortex restrict their possible use in computation. Neuron 2010, 67:885-896. 10.1016/j.neuron.2010.08.004.
39. Salvadore G., Salvadore G., van der Veen J.W., van der Veen J.W., Zhang Y., Zhang Y., Marenco S., Marenco S., Machado-Vieira R., Machado-Vieira R., Baumann J., Baumann J., Ibrahim L.A., Ibrahim L.A., Luckenbaugh D.A., Luckenbaugh D.A., Shen J., Shen J., Drevets W.C., Drevets W.C., Zarate C.A., Zarate C.A. An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression. Int. J. Neuropsychopharmacol. 2011, 1-10. 10.1017/S1461145711001593.
40. Sanacora G., Sanacora G., Zarate C.A., Zarate C.A., Krystal J.H., Krystal J.H., Manji H.K., Manji H.K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug Discov. 2008, 7:426-437. 10.1038/nrd2462.
41. Sanacora G., Smith M.A., Pathak S., Su H.-L., Boeijinga P.H., McCarthy D.J., Quirk M.C. Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects. Mol. Psychiatry 2014, 19:978-985. 10.1038/mp.2013.130.
42. Saxena N., Muthukumaraswamy S.D., Diukova A., Singh K., Hall J., Wise R. Enhanced stimulus-induced gamma activity in humans during propofol-induced sedation. PLoS One 2013, 8:e57685. 10.1371/journal.pone.0057685.
43. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20). 22-33-quiz 34-57.
44. Vrba J., Robinson S. Signal Processing in magnetoencephalography. Methods 2001, 25:249-271. 10.1006/meth.2001.1238.
45. Wierońska J.M., Pałucha-Poniewiera A., Nowak G., Pilic A. Depression viewed as a GABA/glutamate imbalance in the central nervous system. Clin. Res. Treat. Approaches Affect. Disord 2012.
46. Wood J., Kim Y., Moghaddam B. Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs. J. Neurosci. 2012, 32:3022-3031. 10.1523/JNEUROSCI.6377-11.2012.
47. Wood J.D., Hertz L. Ketamine-induced changes in the GABA system of mouse brain. Biol. Psychiatry 1980, 19:805-808.
48. Xing D., Yeh C.-I., Burns S., Shapley R.M. Laminar analysis of visually evoked activity in the primary visual cortex. Proc. Natl. Acad. Sci. USA 2012, 109:13871-13876. 10.1073/pnas.1201478109.
49. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., Manji H.K. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006, 63:856-864. 10.1001/archpsyc.63.8.856.
50. Zilles K., Palomero-Gallagher N., Schleicher A. Transmitter receptors and functional anatomy of the cerebral cortex. J Anat. 2004, 205:417-432. 10.1111/j.0021-8782.2004.00357.x.